{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:33:15Z","timestamp":1787009595687,"version":"build-2736575974"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"UC Davis Comprehensive Cancer Center Pilot","award":["CCSG NCI P30 CA093373"],"award-info":[{"award-number":["CCSG NCI P30 CA093373"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estimation of the lung shunt fraction (LSF) is an integral part of liver radioembolization treatment planning to prevent excessive lung irradiation from arterio-venous shunting in the liver. 99mTc macro-aggregated albumin (99mTc-MAA) nuclear imaging is the standard method. Recent literature suggests that 99mTc-MAA nuclear imaging may be omitted in selected patient populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study investigates the potential of contrast-enhanced computed tomography (CECT) as a non-invasive method for estimating LSF as an alternative for 99mTc-MAA nuclear imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study included 30 consecutive patients who underwent 90Y radioembolization between January 2015 and December 2024, where both four-phase CECT and 99mTc-MAA planar imaging were performed within one month of each other. Hypervascular tumor enhancement was identified on the CECT by subtracting the portal venous phase from the arterial phase and applying an intensity threshold. Additional perfusion characteristics were captured. Statistical analysis assessed the agreement between the CECT-derived volume ratios and the LSF values derived from 99mTc-MAA imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort consisted of 23 male and 7 female patients with a median age of 66\u2009years (interquartile range: 58-71), diagnosed with hepatocellular carcinoma (n\u2009=\u200924), intrahepatic cholangiocarcinoma (n\u2009=\u20092), pancreatic neuroendocrine tumors (n\u2009=\u20092), metastatic colorectal cancer (n\u2009=\u20091), and lymphocyte carcinoma (n\u2009=\u20091). Regression of the hypervascular-tumor-to-perfused volume ratio on CECT against LSF from 99mTc-MAA imaging showed R2\u2009=\u20090.95 (P\u2009&amp;lt;\u2009.001). In contrast, the correlation between tumor volume and LSF was R2\u2009=\u20090.38 (P\u2009=\u2009.001). The root mean square error between the LSF estimated from CECT and that measured using 99mTc-MAA planar imaging was 3%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypervascular-tumor-to-perfused volume ratio computed from CECT may offer a suitable alternative to 99mTc-MAA nuclear imaging for LSF estimation in patients undergoing transarterial radioembolization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/radadv\/umaf025","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T11:52:40Z","timestamp":1754049160000},"source":"Crossref","is-referenced-by-count":3,"title":["Contrast-enhanced CT as a non-invasive alternative for lung shunt fraction estimation in hepatic transarterial radioembolization"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-1837","authenticated-orcid":false,"given":"Brahim","family":"Mehadji","sequence":"first","affiliation":[{"name":"Department of Radiology, University of California Davis , Sacramento, CA 95817,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of California Davis , Davis, CA 95616,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California Davis , Sacramento, CA 95817,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Eric","family":"Goldman","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California Davis , Sacramento, CA 95817,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Tram","family":"Vu","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California Davis , Sacramento, CA 95817,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-1064","authenticated-orcid":false,"given":"Emilie","family":"Roncali","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California Davis , Sacramento, CA 95817,","place":["United States"]},{"name":"Department of Biomedical Engineering, University of California Davis , Davis, CA 95616,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"12","key":"2025082608371247500_umaf025-B1","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2967\/jnumed.121.261954","article-title":"Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: analysis of the US National Cancer Database","volume":"62","author":"Ahn","year":"2021","journal-title":"J Nucl Med"},{"issue":"2","key":"2025082608371247500_umaf025-B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"2025082608371247500_umaf025-B3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.semnuclmed.2019.01.006","article-title":"90Y-loaded microsphere SIRT of HCC patients with portal vein thrombosis: high clinical impact of 99mTc-MAA SPECT\/CT-based dosimetry","volume":"49","author":"Garin","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"3","key":"2025082608371247500_umaf025-B4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/1319-3767.80388","article-title":"Radioembolization for hepatocellular carcinoma using TheraSphere\u00ae","volume":"17","author":"Ali","year":"2011","journal-title":"Saudi J Gastroenterol"},{"issue":"2","key":"2025082608371247500_umaf025-B5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.21037\/jgo.2016.11.08","article-title":"Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"2025082608371247500_umaf025-B6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/RLI.0b013e31829810f7","article-title":"Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases","volume":"48","author":"Morsbach","year":"2013","journal-title":"Invest Radiol"},{"issue":"7","key":"2025082608371247500_umaf025-B7","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.21873\/anticanres.12666","article-title":"Contribution of computed tomographic angiography to pretreatment planning of radio-embolization of liver tumors","volume":"38","author":"Mirka","year":"2018","journal-title":"Anticancer Res"},{"issue":"5","key":"2025082608371247500_umaf025-B8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"2025082608371247500_umaf025-B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/978-3-031-52546-9_39","volume-title":"IR Playbook: A Comprehensive Introduction to Interventional Radiology","author":"Li","year":"2024"},{"issue":"4","key":"2025082608371247500_umaf025-B10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1055\/s-0041-1735616","article-title":"Current approach to planning angiography and MAA administration","volume":"38","author":"Commander","year":"2021","journal-title":"Semin Interv Radiol"},{"issue":"1","key":"2025082608371247500_umaf025-B11","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00837-z","article-title":"Lung shunt fraction calculation using 99mTc-MAA SPECT\/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors","volume":"11","author":"Georgiou","year":"2021","journal-title":"EJNMMI Res"},{"issue":"6","key":"2025082608371247500_umaf025-B12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2020.02.024","article-title":"Streamlining radioembolization in UNOS T1\/T2 hepatocellular carcinoma by eliminating lung shunt estimation","volume":"72","author":"Gabr","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"2025082608371247500_umaf025-B13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025082608371247500_umaf025-B14"},{"issue":"2","key":"2025082608371247500_umaf025-B15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","article-title":"Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group","volume":"50","author":"Salem","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2025082608371247500_umaf025-B16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00270-024-03799-6","article-title":"Single-session ablative transarterial radioembolization for patients with hepatocellular carcinoma to streamline care: an initial experience","volume":"47","author":"Berman","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"2025082608371247500_umaf025-B17","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jvir.2021.03.496","article-title":"Abstract No. 74 single-procedure radioembolization: pilot case series and retrospective analysis on proposed safe size threshold for estimated lung dose exposure in radiation segmentectomy","volume":"32","author":"Farzanegan","year":"2021","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2025082608371247500_umaf025-B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jvir.2024.10.007","article-title":"Streamlining radioembolization without lung shunt estimation versus regular radioembolization in patients with hepatocellular carcinoma within the Milan criteria","volume":"36","author":"Kim","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"2025082608371247500_umaf025-B19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","article-title":"A guide to 90Y radioembolization and its dosimetry","volume":"68","author":"Kim","year":"2019","journal-title":"Phys Med"},{"issue":"4","key":"2025082608371247500_umaf025-B20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.ijrobp.2023.12.049","article-title":"Establishing updated safety standards for independent 99mTc-MAA SPECT\/CT treatment planning in radioembolization","volume":"119","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"2025082608371247500_umaf025-B21","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad6748","article-title":"Translating contrast enhanced computed tomography images to liver radioembolization dose distribution for more comprehensively indicating patients","volume":"69","author":"Mehadji","year":"2024","journal-title":"Phys Med Biol"},{"issue":"4","key":"2025082608371247500_umaf025-B22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11547-024-01946-0","article-title":"Radioembolization for hepatocellular carcinoma: a comparison on dual-phase cone-beam CT, contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT\/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET\/CT","volume":"130","author":"di Gaeta","year":"2025","journal-title":"Radiol Med"},{"issue":"6","key":"2025082608371247500_umaf025-B23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/medicina59061115","article-title":"Angiogenesis and hepatocellular carcinoma: from molecular mechanisms to systemic therapies","volume":"59","author":"Pinto","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"2025082608371247500_umaf025-B24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2967\/jnumed.121.263145","article-title":"Radioembolization dosimetry with total-body 90Y PET","volume":"63","author":"Costa","year":"2022","journal-title":"J Nucl Med"},{"key":"2025082608371247500_umaf025-B25","unstructured":"Perktold J, Seabold S, Sheppard K, et al \u00a0Statsmodels\/Statsmodels: release 0.14.2. Zenado. 2024;17. 10.5281\/ZENODO.593847"},{"issue":"2","key":"2025082608371247500_umaf025-B26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1148\/radiol.14130091","article-title":"CT perfusion of the liver: principles and applications in oncology","volume":"272","author":"Kim","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"2025082608371247500_umaf025-B27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"2025082608371247500_umaf025-B28","author":"Itseez"},{"issue":"1","key":"2025082608371247500_umaf025-B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40658-021-00394-3","article-title":"EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres","volume":"8","author":"Chiesa","year":"2021","journal-title":"EJNMMI Phys"},{"key":"2025082608371247500_umaf025-B30","volume-title":"Scikit-Learn: Machine Learning in Python","author":"Pedregosa"},{"issue":"3","key":"2025082608371247500_umaf025-B31","doi-asserted-by":"publisher","first-page":"uaae016","DOI":"10.1093\/bjrcr\/uaae016","article-title":"Implications of lung shunt fraction calculation discrepancy in Yttrium-90 radioembolization treatment from 2D planar vs 3D single photon emission CT imaging","volume":"10","author":"Kubota","year":"2024","journal-title":"BJR Case Rep"},{"issue":"9","key":"2025082608371247500_umaf025-B32","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1002\/mp.13575","article-title":"Calculation of lung mean dose and quantification of error for 90Y-microsphere radioembolization using 99mTc-MAA SPECT\/CT and diagnostic chest CT","volume":"46","author":"Lopez","year":"2019","journal-title":"Med Phys"},{"issue":"6","key":"2025082608371247500_umaf025-B33","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/tomography8060224","article-title":"Prediction of lung shunt fraction for Yttrium-90 treatment of hepatic tumors using dynamic contrast enhanced MRI with quantitative perfusion processing","volume":"8","author":"Zhang","year":"2022","journal-title":"Tomography"},{"issue":"7","key":"2025082608371247500_umaf025-B34","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2967\/jnumed.121.263143","article-title":"Lung dose measured on postradioembolization 90Y PET\/CT and incidence of radiation pneumonitis","volume":"63","author":"Stella","year":"2022","journal-title":"J Nucl Med"}],"container-title":["Radiology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/radadv\/advance-article-pdf\/doi\/10.1093\/radadv\/umaf025\/63927945\/umaf025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/radadv\/article-pdf\/2\/4\/umaf025\/63927945\/umaf025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/radadv\/article-pdf\/2\/4\/umaf025\/63927945\/umaf025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:37:19Z","timestamp":1756211839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/radadv\/article\/doi\/10.1093\/radadv\/umaf025\/8221777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/radadv\/umaf025","relation":{},"ISSN":["2976-9337"],"issn-type":[{"value":"2976-9337","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]},"article-number":"umaf025"}}